Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia
Expanded Access Protocol for the Treatment Use of HBOC-201
Sponsor: Englewood Hospital and Medical Center
Listed as NCT01881503, this NA trial focuses on Anemia and remains ongoing. Sponsored by Englewood Hospital and Medical Center, it has been updated 14 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
May 2025 — Present [monthly]
Enrolling By Invitation NA
Status: Unknown → Enrolling By Invitation
-
Sep 2024 — May 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Sep 2021 — Jan 2024 [monthly]
Enrolling By Invitation NA
▶ Show 9 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Enrolling By Invitation NA
-
Mar 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
-
Oct 2018 — Mar 2020 [monthly]
Enrolling By Invitation NA
-
Sep 2018 — Oct 2018 [monthly]
Enrolling By Invitation NA
-
Jul 2018 — Sep 2018 [monthly]
Enrolling By Invitation NA
-
Jun 2018 — Jul 2018 [monthly]
Enrolling By Invitation NA
-
Aug 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
Status: Recruiting → Enrolling By Invitation
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Englewood Hospital and Medical Center
- HbO2 Therapeutics LLC
For direct contact, visit the study record on ClinicalTrials.gov .